|
|
Trends in age-, period- and cohort-specific incidence of hepatitis C in Jingzhou City from 2008 to 2022 |
LIU Rui, LIN Maowen, JIANG Hong, LI Shuchao, ZHANG Fan, SUN Chun
|
Department of AIDS/STD Control and Prevention, Jingzhou Center for Disease Control and Prevention, Jingzhou, Hubei 434000, China |
|
|
Abstract Objective To investigate the trend in incidence of hepatitis C in Jingzhou City, Hubei Province from 2008 to 2022, and to examine the age-period-cohort effect, so as to provide the basis for the formulation of hepatitis C prevention strategies. Methods Demographic data and incidence data of hepatitis C in Jingzhou City from 2008 to 2022 were collected through the Chinese Disease Prevention and Control Information System, and the trend in incidence of hepatitis C was analyzed using average annual percent change (AAPC) and annual percent change (APC). The effects of age, period and cohort on the incidence of hepatitis C were examined with an age-period-cohort model. Results The average annual incidence of hepatitis C in Jingzhou City from 2008 and 2022 was 20.26/105, with a male incidence of 20.04/105 and a female incidence of 20.47/105. The incidence of hepatitis C initially rose and then fell (AAPC=5.375%, P<0.05), with a rising trend from 2008 to 2018 (APC=13.370%, P<0.05) and a decreasing trend from 2018 to 2022 (APC=-12.231%, P<0.05). The incidence of hepatitis C appeared a tendency towards a rise with age, and the 80-84 age group had the highest risk (RR=11.420, 95%CI: 7.631-17.090) in relative to the 45-49 age group. The incidence of hepatitis C appeared a tendency towards a rise followed by a decline with time, and an increased risk of hepatitis C was seen from 2013 to 2017 (RR=1.393, 95%CI: 1.272-1.525) and a decreased risk was seen from 2018 to 2022 (RR=1.237, 95%CI: 1.072-1.428) in relative to the period from 2008 to 2012. The incidence of hepatitis C appeared a tendency towards a rise followed by a decline with the cohort, and a higher risk was found in the 1965-1984 cohort (all RR>1.300) in relative to the 1960-1964 cohort. The incidence of hepatitis C, the age and period effects in men and women, and the cohort effects in men were consistent with the whole population. In addition to the 1965-1984 cohort, a higher risk was found in the 2000-2014 cohort in women (all RR>1.250). Conclusions From 2008 to 2022, the incidence of hepatitis C in Jingzhou City experienced a notable rise and subsequent decline. The incidence of hepatitis C increased with age, with higher risks seen among middle-aged and elderly people.
|
Received: 17 July 2023
Revised: 26 August 2023
Published: 10 October 2023
|
|
|
|
|
[1] 中华医学会肝病学分会,中华医学会感染病学分会.丙型肝炎防治指南(2022年版)[J].中华肝脏病杂志,2022,30(12):1332-1348. [2] World Health Organization.Hepatitis C[EB/OL].[2023-08-26].https://www.who.int/news-room/fact-sheets/detail/hepatitis-c. [3] 刘小畅,赵婷,赵志梅,等.中国居民病毒性肝炎流行趋势分析[J].预防医学,2018,30(5):433-437. [4] 李健,庞琳,王晓春,等.中国丙型肝炎防治进展与展望[J].中国艾滋病性病,2022,28(7):761-765. [5] 吴景涛,宇传华,王雷,等.2004—2018年湖北省丙型肝炎流行特征与趋势[J].中华疾病控制杂志,2020,24(4):451-455. [6] 黄照,马文军.年龄-时期-队列模型[J].华南预防医学,2017,43(4):373-376. [7] 郑伟,张世勇,杨纶砥,等.基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J].预防医学,2023,35(8):665-668. [8] 马莹莹,李丽娟.我国丙型病毒性肝炎分布综述[J].昆明学院学报,2020,42(6):98-101. [9] 中华人民共和国国家卫生和计划生育委员会.丙型肝炎诊断:WS 213—2018[S].2018. [10] 中华人民共和国国家卫生和计划生育委员会,发展改革委员会,教育部,等.关于印发中国病毒性肝炎防治规划(2017—2020年)的通知[A/OL].[2023-08-26].https://www.gov.cn/gongbao/content/2018/content_5271799.htm. [11] 中华人民共和国国家卫生健康委员会.关于印发消除丙型肝炎公共卫生危害行动工作方案(2021—2030年)的通知[A/OL].[2023-08-26].http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml. [12] 陈楚莹,陈秀云,王曼,等.2006—2019年中山市丙型病毒性肝炎报告发病率的年龄-时期-队列分析[J].中华疾病控制杂志,2021,25(7):775-778. [13] 王辛未,孙群露,饶展宏,等.2005—2016年深圳市宝安区丙型肝炎报告发病率的年龄-时期-队列分析[J].中国艾滋病性病,2018,24(3):268-271. [14] 董琬铮. 医美行业在中国的发展趋势[J].江苏商论,2021(12):3-5. [15] 屈凌霄,施阳,陈恺韵,等.上海市2014—2019年丙型肝炎综合监测分析[J].中华流行病学杂志,2021,42(4):626-631. [16] 孙峰华,刘继生,李世泰.中国毒品的来源及其空间扩散[J].吉首大学学报(自然科学版),2003,24(2):66-70,92. [17] 于雪,魏雨虹.医美消费低龄化,“00后”在健康求美吗?[EB/OL].[2023-08-26].http://lw.news.cn/2022-11/21/c_1310678286.htm. |
|
|
|